Metabolic & Cardiometabolic
oxidized LDL (not native LDL) causes initiation of atherosclerotic lesions
In plain terms: Does LDL only cause heart disease after it gets oxidized?
Part of: 🔍 seed oils
Oxidized LDL is real and drives many steps of plaque biology, but antioxidant trials failed to cut heart attacks and LDL/ApoB particle number is the proven causal driver, so "native LDL is harmless until oxidized" is overstated.
📅 Last reviewed: 2026-07-14 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
Oxidised LDL is real and drives many steps of plaque biology, and circulating levels predict coronary events. The initiation claim fails its own test: antioxidant trials that should have interrupted the pathway did not reduce cardiovascular events, and the consensus from Mendelian randomisation and trials is that LDL particle number causes disease log-linearly, oxidised or not.
The evidence (12)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Schiopu A, Björkbacka H, Narasimhan G, Loong BJ, Engström G, Melander O, Orho-Melander M, Nilsson J 2023 · Ann Med | observational | supports | moderate | Elevated circulating soluble LOX-1 (the oxLDL receptor) prospectively predicted first myocardial infarction, supporting a real contributory role for oxLDL biology. |
| Williams KJ, Tabas I 1998 · Curr Opin Lipidol | mechanism | mixed | moderate | Review, not evidence: 'We review recent experimental work that has substantially reinforced this hypothesis' — 'the key initiating event in early atherosclerosis is the subendothelial retention of cholesterol-rich, atherogenic lipoproteins.' Review — zero weight. |
| Violi F, Nocella C, Loffredo L, Carnevale R, Pignatelli P 2022 · Free Radic Biol Med | meta-analysis | contradicts | moderate | Despite strong oxLDL mechanism, interventional vitamin E antioxidant trials failed to reduce cardiovascular events, arguing against oxidation being the necessary causal gate. |
| Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, Hegele RA, Krauss RM, Raal FJ, Schunkert H, Watts GF, Borén J, Fazio S, Horton JD, Masana L, Nicholls SJ, Nordestgaard BG, van de Sluis B, Taskinen MR, Tokgözoglu L, Landmesser U, Laufs U, Wiklund O, Stock JK, Chapman MJ, Catapano AL 2017 · European Heart Journal | observational | contradicts | high | EAS consensus from Mendelian-randomization + RCTs: LDL/ApoB particle number causes ASCVD log-linearly — native LDL is NOT benign, undercutting "must oxidize first". |
| Meisinger C, Baumert J, Khuseyinova N, Loewel H, Koenig W 2005 · Circulation | observational | supports | high | In healthy middle-aged men, plasma oxLDL was a strong independent predictor of future coronary events — human prospective support. |
| Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL 1989 · N Engl J Med | mechanism | supports | moderate | Landmark "beyond cholesterol" hypothesis: oxidative modification makes LDL atherogenic via scavenger-receptor foam-cell uptake — foundational mechanism. |
| An P, Wan S, Luo Y, Luo J, Zhang X, Zhou S, Xu T, He J, Mechanick JI, Wu WC, Ren F, Liu S 2022 · J Am Coll Cardiol | meta-analysis | tested-null | high | Broad micronutrient meta-analysis: vitamin E and most antioxidants showed no CVD benefit, reinforcing that lowering oxidation is not the lever LDL-lowering is. |
| Alkhenizan AH, Al-Omran MA 2004 · Saudi Med J | meta-analysis | tested-null | moderate | Nine vitamin-E RCTs (n=80,645): no reduction in total or CVD mortality — antioxidant strategy fails to confirm oxidation-as-initiator. |
| Zhao Y, Xu Q, He N, Jiang M, Chen Y, Ren Z, Tang Z, Wu C, Liu L 2024 · Curr Med Chem | mechanism | supports | moderate | Narrative review (no new data) of non-oxidative LDL modifications - such as carbamylation, glycation and enzymatic modification - as additional drivers of atherosclerosis. The authors themselves accept that oxidised LDL 'is recognized as the most important and independent risk factor in initiating and promoting atherosclerosis', and cite the failure of antioxidant therapy to reduce cardiovascular events as a reason to study the other modifications too, not as evidence that oxidised LDL does not initiate lesions. Abstract only. |
| Chisolm GM, Steinberg D 2000 · Free Radic Biol Med | mechanism | mixed | moderate | Perspective review by the hypothesis's originators, no new data: 'This brief review is not intended to be comprehensive but rather to offer a perspective and a context for this Forum.' Concedes 'it is still not known how and where LDL gets oxidized in vivo nor which of its many biological effects demonstrable in vitro are relevant to atherogenesis in vivo.' Zero weight. |
| Torzewski M 2021 · Int J Mol Sci | observational | contradicts | low | Argues early lesion initiation proceeds via enzymatically (non-oxidatively) modified LDL and can begin without inflammation, contradicting the claim that oxidation is the required trigger. |
| Ye Y, Li J, Yuan Z 2013 · PLoS One | meta-analysis | tested-null | high | Pooled antioxidant-vitamin RCTs (vit E, C, beta-carotene) showed no reduction in cardiovascular events — predicted benefit of blocking LDL oxidation did not materialize. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.